Current Situation in Control Strategies and Health Systems in Asia - Sri Lanka by Rasnayaka M Mudiyanse, Senior Lecturer in Paediatrics at the University of Peradeniya and Consultant Paediatrician at the Teaching Hospital in Peradeniya.
This document provides an overview and update on gender differences in the treatment of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). Some key points summarized:
1) Women have historically experienced later referrals for treatment of ACS, resulting in more advanced coronary artery disease and worse outcomes. However, outcomes after PCI have improved over time for both men and women.
2) Women continue to be underrepresented in clinical trials of PCI due to barriers like later presentation and higher risk profiles making them ineligible.
3) While early data showed gender was an independent predictor of mortality after PCI, more recent studies have found no differences in death or re-intervention rates between men and women after adjusting for
Faisal Ahmed - Una aproximación sistemática a las diferencias del desarrollo ...Fundación Ramón Areces
os días 22 y 23 de octubre de 2015, organizamos en la Fundación Ramón Areces un Simposio Internacional sobre un área prioritaria para esta institución: la investigación de las enfermedades raras. En este caso, las doctoras Susan Webb y Eugenia Resmini, del Hospital de la Santa Creu i Sant Pau de Barcelona, coordinaron un encuentro científico sobre 'Enfermedades raras endocrinas, de la investigación al manejo clínico'.
This document summarizes a review study comparing treatment results for prostate cancer. Over 21,000 prostate studies published between 2000-2011 were reviewed, with 145 meeting criteria for inclusion. Experts from various treatment disciplines (e.g. surgery, radiation) assembled to conduct a complete literature review on prostate cancer treatment success rates based on PSA levels. Results are presented separating patients into low, intermediate, and high risk groups.
Primary Care direct access to thyroid ultrasound: Audit of clinical efficienc...u.surgery
This document describes an audit of primary care referrals for thyroid ultrasound (TUS) before and after the implementation of a one stop thyroid diagnostic clinic. The audit found that primary care access to TUS did not improve detection of thyroid pathology and led to inefficiencies. After establishing a one stop clinic with standardized referral criteria and risk assessment, more suspicious nodules were biopsied, detection of neoplasms increased, and follow-up of inconclusive results improved. The audit concluded that limiting primary care access to TUS and routing patients through a specialized one stop clinic enhances efficiency and quality in evaluating thyroid nodules.
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053BartsMSBlog
Alemtuzumab demonstrated durable efficacy and a consistent safety profile over 10 years in patients with relapsing-remitting multiple sclerosis (RRMS) from the CAMMS223 study. Most patients maintained a low annualized relapse rate and experienced stabilization or improvement in disability scores. While adverse events were most common in the first year, serious safety issues were rare, with infections declining over time and no deaths occurring. Alemtuzumab provided sustained benefit for RRMS with limited additional treatment for many patients over 10 years.
This document discusses statistical concepts and tests relevant to epidemiology and biomedical research. It begins by defining key terms like mean, standard deviation, confidence intervals, and p-values. It then discusses different types of data and variables, measures of central tendency, the central limit theorem, and applications of standard error. The document provides examples of choosing appropriate statistical tests for different study designs, including t-tests, ANOVA, chi-square, correlation, and comparing means between two or more groups. Finally, it presents a case study analyzing water-borne disease deaths before and after a water supply installation using appropriate statistical tests.
Pragmatic Open-Label Randomized Trial of Pre-Exposure Prophylaxis: the PROUD ...Office of HIV Planning
Kathleen Brady of the Philadelphia Department of Public Health shared slides about the PROUD study, originally presented at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI), at the March 2015 meeting of the Philadelphia HIV Prevention Planning Group (HPG).
Current Situation in Control Strategies and Health Systems in Asia - Sri Lanka by Rasnayaka M Mudiyanse, Senior Lecturer in Paediatrics at the University of Peradeniya and Consultant Paediatrician at the Teaching Hospital in Peradeniya.
This document provides an overview and update on gender differences in the treatment of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). Some key points summarized:
1) Women have historically experienced later referrals for treatment of ACS, resulting in more advanced coronary artery disease and worse outcomes. However, outcomes after PCI have improved over time for both men and women.
2) Women continue to be underrepresented in clinical trials of PCI due to barriers like later presentation and higher risk profiles making them ineligible.
3) While early data showed gender was an independent predictor of mortality after PCI, more recent studies have found no differences in death or re-intervention rates between men and women after adjusting for
Faisal Ahmed - Una aproximación sistemática a las diferencias del desarrollo ...Fundación Ramón Areces
os días 22 y 23 de octubre de 2015, organizamos en la Fundación Ramón Areces un Simposio Internacional sobre un área prioritaria para esta institución: la investigación de las enfermedades raras. En este caso, las doctoras Susan Webb y Eugenia Resmini, del Hospital de la Santa Creu i Sant Pau de Barcelona, coordinaron un encuentro científico sobre 'Enfermedades raras endocrinas, de la investigación al manejo clínico'.
This document summarizes a review study comparing treatment results for prostate cancer. Over 21,000 prostate studies published between 2000-2011 were reviewed, with 145 meeting criteria for inclusion. Experts from various treatment disciplines (e.g. surgery, radiation) assembled to conduct a complete literature review on prostate cancer treatment success rates based on PSA levels. Results are presented separating patients into low, intermediate, and high risk groups.
Primary Care direct access to thyroid ultrasound: Audit of clinical efficienc...u.surgery
This document describes an audit of primary care referrals for thyroid ultrasound (TUS) before and after the implementation of a one stop thyroid diagnostic clinic. The audit found that primary care access to TUS did not improve detection of thyroid pathology and led to inefficiencies. After establishing a one stop clinic with standardized referral criteria and risk assessment, more suspicious nodules were biopsied, detection of neoplasms increased, and follow-up of inconclusive results improved. The audit concluded that limiting primary care access to TUS and routing patients through a specialized one stop clinic enhances efficiency and quality in evaluating thyroid nodules.
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053BartsMSBlog
Alemtuzumab demonstrated durable efficacy and a consistent safety profile over 10 years in patients with relapsing-remitting multiple sclerosis (RRMS) from the CAMMS223 study. Most patients maintained a low annualized relapse rate and experienced stabilization or improvement in disability scores. While adverse events were most common in the first year, serious safety issues were rare, with infections declining over time and no deaths occurring. Alemtuzumab provided sustained benefit for RRMS with limited additional treatment for many patients over 10 years.
This document discusses statistical concepts and tests relevant to epidemiology and biomedical research. It begins by defining key terms like mean, standard deviation, confidence intervals, and p-values. It then discusses different types of data and variables, measures of central tendency, the central limit theorem, and applications of standard error. The document provides examples of choosing appropriate statistical tests for different study designs, including t-tests, ANOVA, chi-square, correlation, and comparing means between two or more groups. Finally, it presents a case study analyzing water-borne disease deaths before and after a water supply installation using appropriate statistical tests.
Pragmatic Open-Label Randomized Trial of Pre-Exposure Prophylaxis: the PROUD ...Office of HIV Planning
Kathleen Brady of the Philadelphia Department of Public Health shared slides about the PROUD study, originally presented at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI), at the March 2015 meeting of the Philadelphia HIV Prevention Planning Group (HPG).
This document describes a project in Romania to establish a multidisciplinary network approach for managing Prader-Willi syndrome and Angelman syndrome. The project involves 8 partner institutions and aims to implement new diagnostic methods, establish national expertise centers, collaborate with patient associations, and develop international partnerships. The goals are to create standardized clinical evaluation protocols, establish a national patient registry, and integrate a multidisciplinary care approach for patients.
The document discusses the case of a 62-year-old man who experienced a transient ischemic attack. It summarizes the diagnostic workup, including imaging and vascular testing, to determine if the patient had a stroke and the location of any blockages. The document then reviews the evidence and guidelines for treatment of carotid artery disease, including whether the patient is a surgical candidate. Overall, the key information provided is on evaluating and treating patients who experience transient ischemic attacks or minor strokes due to carotid artery disease.
- The study compared ocrelizumab (OCR) to placebo in treating primary progressive multiple sclerosis (PPMS) over approximately 3 years. Baseline characteristics were balanced between the treatment groups.
- OCR met the primary endpoint of reducing disability progression confirmed at 12 weeks compared to placebo. Key secondary endpoints including disability progression at 24 weeks, timed walking test, brain lesion volume, and brain volume loss were also significantly improved by OCR compared to placebo.
- Adverse events including infections were more common with OCR, but serious adverse events and discontinuation due to adverse events were similar between groups. Safety analyses are ongoing given a higher number of reported cancers with OCR, but differences must be considered in
This document summarizes highlights from the 2020 Annual Meeting of the American Society for Bone and Mineral Research (ASBMR). Key points include: research on the relationship between dietary advanced glycation end-products and bone health; a trial showing that dairy supplementation reduced fractures and falls in older adults; and findings that high-dose vitamin D supplementation affected bone density differently in females versus males. Other topics discussed were treat-to-target approaches in osteoporosis and probabilities of achieving bone mineral density goals with different treatment sequences.
Current Care of Thalassaemia Major Patients in Hong Kong, China by Vincent Lee, Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong
1) A study examined the effect of warfarin genotyping on outcomes in patients initiating warfarin therapy, comparing an intervention group that received genotyping to historical controls.
2) The intervention group had significantly lower rates of hospitalization for all causes (28% decrease) and for bleeding/thromboembolism (27% decrease) over 6 months.
3) Physicians changed warfarin prescriptions according to genotype results, suggesting genotyping helped improve dosing and reduce adverse events during initial warfarin treatment.
This document summarizes a study comparing the results of different treatments for prostate cancer. A group of experts assembled to conduct a comprehensive review of over 25,000 prostate studies published between 2000-2012. They identified 218 studies that met their criteria for comparing cancer control rates of treatments including surgery, radiation therapy, brachytherapy, high intensity focused ultrasound, and proton beam therapy. The group analyzed success rates for each treatment based on patients' prostate-specific antigen levels as an indicator of cancer progression over time.
Diagnostic Testing for Mitochondrial Diseasemitoaction
Review traditional diagnostic pathways
Discuss newer testing that has become available in recent years
Review new approaches to attempt to shorten time to diagnosis and increase precision
There appears to be a higher cancer control success rate for Brachy over EBRT and Surgery for all groups. Patients are encouraged to look at graphs and determine for themselves
This document discusses the management of low risk prostate cancer. It outlines the natural history of untreated low risk prostate cancer and the problems of overdiagnosis and overtreatment. Active surveillance is presented as a management option for low risk prostate cancer, with the rationale being to avoid unnecessary treatment and preserve quality of life. Results from active surveillance studies show low rates of cancer progression and metastasis, with 62% free from intervention at 10 years in one study. Triggers for intervention on active surveillance like rising PSA, grade progression, or tumor volume increase are discussed.
Problem: Patients, physicians and carriers need a simple, unbiased means to compare the cancer control rates of modern prostate cancer treatment methods. To solve this problem, we have assembled experts from key treating disciplines: Surgery, External Radiation, Internal (or Brachytherapy), High Frequency Ultrasound, and Proton Therapy to do a complete review study of the current literature on prostate cancer treatment.
This study examined predictors of contralateral breast cancer in unilateral breast cancer patients undergoing contralateral prophylactic mastectomy (CPM). The study analyzed 542 patients who underwent CPM at one cancer center between 2000-2007. Univariate analysis found that younger age, Gail risk score >1.67%, ipsilateral invasive lobular histology, additional ipsilateral moderate-high risk pathology, and multicentric ipsilateral tumor predicted higher risk of contralateral breast cancer. However, multivariate analysis identified only younger age and ipsilateral invasive lobular histology as independent predictors of contralateral breast cancer. The study aimed to help identify which unilateral breast cancer patients might most benefit from CPM.
Australasian Laparoscopic Colon Cancer Studyensteve
- ALCCaS is a multi-center randomized controlled trial comparing laparoscopic and open surgery for colon cancer in Australia and New Zealand that recruited 600 patients between 1999-2008.
- The primary aims are to compare 5-year mortality and tumor recurrence rates between the two surgical methods. Secondary aims look at short-term outcomes like complications, recovery time, and costs.
- Over the study period, 592 patients were recruited across 7 centers by 34 surgeons. Data collection is now complete and results will be analyzed to determine if laparoscopic surgery is as safe and effective as open surgery for colon cancer.
Localized Prostate Cancer in Puerto Ricoflasco_org
This document summarizes localized prostate cancer screening and treatment options in Puerto Rico. It discusses screening guidelines and biomarkers like PSA, PCA3, and multiparametric MRI. Treatment options covered include active surveillance, surgery (open, robotic, cryotherapy), and radiation therapy (brachytherapy, external beam). Robotic prostatectomy results in less blood loss and shorter catheter time compared to open surgery. Adjuvant radiation after prostatectomy may improve outcomes for men with adverse features like positive margins or extraprostatic extension.
The document discusses screening and active surveillance for prostate cancer. It summarizes that screening with PSA testing can reduce prostate cancer mortality by 20% but also leads to overdiagnosis of indolent cancers. Active surveillance is presented as an alternative to immediate treatment for selected low-risk prostate cancer patients with criteria such as Gleason score ≤6, PSA<10ng/ml, and limited cancer in biopsy cores. Studies found that 29-50% of patients identified by screening as low-risk were found to have more aggressive cancer upon undergoing radical prostatectomy.
The document describes the development and benefits of an Acute Oncology Service (AOS) pathway for patients presenting with suspected or newly diagnosed cancer. It discusses how the AOS set up direct referral pathways for radiologists to refer patients with suspicious imaging findings. This allows for rapid assessment, diagnosis, and initiation of treatment. The pathway is shown to reduce delays and improve patient experience compared to traditional 2 week wait referrals. Audit data found the pathway effective while also identifying opportunities to better manage non-cancer patients. Overall, the AOS approach aims to provide coordinated, rapid, and symptom-focused care for patients with potential or new cancer diagnoses.
Low Dose Radiation Therapy (LDRT) for COVID-19 PneumoniaMatthew Katz
The COVID-19 pandemic has galvanized research on how to treat people ill enough to be hospitalized with SARS-CoV-2 pneumonia. Radiation therapy is being evaluated in clinical trials as an investigational treatment. This presentation from July was for colleagues at Massachusetts General Hospital to discuss the pros/cons of using radiotherapy for an infectious disease.
The document summarizes research on active surveillance for prostate cancer. It discusses definitions of clinically significant prostate cancer, criteria for active surveillance candidacy, biomarkers like PSA kinetics and PCA3, and outcomes of patients on surveillance like cancer-specific survival rates and rates of remaining free from intervention. It concludes that active surveillance appears safe in the intermediate term but challenges remain in identifying higher risk disease and validating triggers for intervention.
- Ocrelizumab (OCR) significantly reduced disability progression and disease activity in patients with primary progressive multiple sclerosis (PPMS) compared to placebo in the ORATORIO clinical trial.
- Evaluation of efficacy in subgroups of patients with and without T1 gadolinium-enhancing (Gd+) lesions at baseline was a key objective. OCR reduced disability progression and disease activity in both subgroups.
- Specifically, OCR reduced the risk of 12-week and 24-week confirmed disability progression by 24-25% in the overall population and in both subgroups. It also reduced the worsening of walking ability and brain lesion volume over 120 weeks compared to placebo.
Bone marrow transplantation for thalassemia in lower resource settings - The Cure2Children Foundation experience in Pakistan. By Dr Naila Yaqub, Assistant Professor, Bone Marrow Transplant unit, The Children hospital, PIMS, Pakistan
The document discusses challenges in treating hemophilia in China. It notes complications like inhibitor development and viral infections. Affordability, availability, and patient compliance are also challenges. Adherence to secondary prophylaxis decreases with age. Barriers to prophylaxis include access issues and perceptions of risk. The status of hemophilia care and treatment in China has improved in recent decades due to efforts like establishing a national hemophilia registry and regional networks, expanding insurance coverage and product availability, and increasing awareness and education.
This document describes a project in Romania to establish a multidisciplinary network approach for managing Prader-Willi syndrome and Angelman syndrome. The project involves 8 partner institutions and aims to implement new diagnostic methods, establish national expertise centers, collaborate with patient associations, and develop international partnerships. The goals are to create standardized clinical evaluation protocols, establish a national patient registry, and integrate a multidisciplinary care approach for patients.
The document discusses the case of a 62-year-old man who experienced a transient ischemic attack. It summarizes the diagnostic workup, including imaging and vascular testing, to determine if the patient had a stroke and the location of any blockages. The document then reviews the evidence and guidelines for treatment of carotid artery disease, including whether the patient is a surgical candidate. Overall, the key information provided is on evaluating and treating patients who experience transient ischemic attacks or minor strokes due to carotid artery disease.
- The study compared ocrelizumab (OCR) to placebo in treating primary progressive multiple sclerosis (PPMS) over approximately 3 years. Baseline characteristics were balanced between the treatment groups.
- OCR met the primary endpoint of reducing disability progression confirmed at 12 weeks compared to placebo. Key secondary endpoints including disability progression at 24 weeks, timed walking test, brain lesion volume, and brain volume loss were also significantly improved by OCR compared to placebo.
- Adverse events including infections were more common with OCR, but serious adverse events and discontinuation due to adverse events were similar between groups. Safety analyses are ongoing given a higher number of reported cancers with OCR, but differences must be considered in
This document summarizes highlights from the 2020 Annual Meeting of the American Society for Bone and Mineral Research (ASBMR). Key points include: research on the relationship between dietary advanced glycation end-products and bone health; a trial showing that dairy supplementation reduced fractures and falls in older adults; and findings that high-dose vitamin D supplementation affected bone density differently in females versus males. Other topics discussed were treat-to-target approaches in osteoporosis and probabilities of achieving bone mineral density goals with different treatment sequences.
Current Care of Thalassaemia Major Patients in Hong Kong, China by Vincent Lee, Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong
1) A study examined the effect of warfarin genotyping on outcomes in patients initiating warfarin therapy, comparing an intervention group that received genotyping to historical controls.
2) The intervention group had significantly lower rates of hospitalization for all causes (28% decrease) and for bleeding/thromboembolism (27% decrease) over 6 months.
3) Physicians changed warfarin prescriptions according to genotype results, suggesting genotyping helped improve dosing and reduce adverse events during initial warfarin treatment.
This document summarizes a study comparing the results of different treatments for prostate cancer. A group of experts assembled to conduct a comprehensive review of over 25,000 prostate studies published between 2000-2012. They identified 218 studies that met their criteria for comparing cancer control rates of treatments including surgery, radiation therapy, brachytherapy, high intensity focused ultrasound, and proton beam therapy. The group analyzed success rates for each treatment based on patients' prostate-specific antigen levels as an indicator of cancer progression over time.
Diagnostic Testing for Mitochondrial Diseasemitoaction
Review traditional diagnostic pathways
Discuss newer testing that has become available in recent years
Review new approaches to attempt to shorten time to diagnosis and increase precision
There appears to be a higher cancer control success rate for Brachy over EBRT and Surgery for all groups. Patients are encouraged to look at graphs and determine for themselves
This document discusses the management of low risk prostate cancer. It outlines the natural history of untreated low risk prostate cancer and the problems of overdiagnosis and overtreatment. Active surveillance is presented as a management option for low risk prostate cancer, with the rationale being to avoid unnecessary treatment and preserve quality of life. Results from active surveillance studies show low rates of cancer progression and metastasis, with 62% free from intervention at 10 years in one study. Triggers for intervention on active surveillance like rising PSA, grade progression, or tumor volume increase are discussed.
Problem: Patients, physicians and carriers need a simple, unbiased means to compare the cancer control rates of modern prostate cancer treatment methods. To solve this problem, we have assembled experts from key treating disciplines: Surgery, External Radiation, Internal (or Brachytherapy), High Frequency Ultrasound, and Proton Therapy to do a complete review study of the current literature on prostate cancer treatment.
This study examined predictors of contralateral breast cancer in unilateral breast cancer patients undergoing contralateral prophylactic mastectomy (CPM). The study analyzed 542 patients who underwent CPM at one cancer center between 2000-2007. Univariate analysis found that younger age, Gail risk score >1.67%, ipsilateral invasive lobular histology, additional ipsilateral moderate-high risk pathology, and multicentric ipsilateral tumor predicted higher risk of contralateral breast cancer. However, multivariate analysis identified only younger age and ipsilateral invasive lobular histology as independent predictors of contralateral breast cancer. The study aimed to help identify which unilateral breast cancer patients might most benefit from CPM.
Australasian Laparoscopic Colon Cancer Studyensteve
- ALCCaS is a multi-center randomized controlled trial comparing laparoscopic and open surgery for colon cancer in Australia and New Zealand that recruited 600 patients between 1999-2008.
- The primary aims are to compare 5-year mortality and tumor recurrence rates between the two surgical methods. Secondary aims look at short-term outcomes like complications, recovery time, and costs.
- Over the study period, 592 patients were recruited across 7 centers by 34 surgeons. Data collection is now complete and results will be analyzed to determine if laparoscopic surgery is as safe and effective as open surgery for colon cancer.
Localized Prostate Cancer in Puerto Ricoflasco_org
This document summarizes localized prostate cancer screening and treatment options in Puerto Rico. It discusses screening guidelines and biomarkers like PSA, PCA3, and multiparametric MRI. Treatment options covered include active surveillance, surgery (open, robotic, cryotherapy), and radiation therapy (brachytherapy, external beam). Robotic prostatectomy results in less blood loss and shorter catheter time compared to open surgery. Adjuvant radiation after prostatectomy may improve outcomes for men with adverse features like positive margins or extraprostatic extension.
The document discusses screening and active surveillance for prostate cancer. It summarizes that screening with PSA testing can reduce prostate cancer mortality by 20% but also leads to overdiagnosis of indolent cancers. Active surveillance is presented as an alternative to immediate treatment for selected low-risk prostate cancer patients with criteria such as Gleason score ≤6, PSA<10ng/ml, and limited cancer in biopsy cores. Studies found that 29-50% of patients identified by screening as low-risk were found to have more aggressive cancer upon undergoing radical prostatectomy.
The document describes the development and benefits of an Acute Oncology Service (AOS) pathway for patients presenting with suspected or newly diagnosed cancer. It discusses how the AOS set up direct referral pathways for radiologists to refer patients with suspicious imaging findings. This allows for rapid assessment, diagnosis, and initiation of treatment. The pathway is shown to reduce delays and improve patient experience compared to traditional 2 week wait referrals. Audit data found the pathway effective while also identifying opportunities to better manage non-cancer patients. Overall, the AOS approach aims to provide coordinated, rapid, and symptom-focused care for patients with potential or new cancer diagnoses.
Low Dose Radiation Therapy (LDRT) for COVID-19 PneumoniaMatthew Katz
The COVID-19 pandemic has galvanized research on how to treat people ill enough to be hospitalized with SARS-CoV-2 pneumonia. Radiation therapy is being evaluated in clinical trials as an investigational treatment. This presentation from July was for colleagues at Massachusetts General Hospital to discuss the pros/cons of using radiotherapy for an infectious disease.
The document summarizes research on active surveillance for prostate cancer. It discusses definitions of clinically significant prostate cancer, criteria for active surveillance candidacy, biomarkers like PSA kinetics and PCA3, and outcomes of patients on surveillance like cancer-specific survival rates and rates of remaining free from intervention. It concludes that active surveillance appears safe in the intermediate term but challenges remain in identifying higher risk disease and validating triggers for intervention.
- Ocrelizumab (OCR) significantly reduced disability progression and disease activity in patients with primary progressive multiple sclerosis (PPMS) compared to placebo in the ORATORIO clinical trial.
- Evaluation of efficacy in subgroups of patients with and without T1 gadolinium-enhancing (Gd+) lesions at baseline was a key objective. OCR reduced disability progression and disease activity in both subgroups.
- Specifically, OCR reduced the risk of 12-week and 24-week confirmed disability progression by 24-25% in the overall population and in both subgroups. It also reduced the worsening of walking ability and brain lesion volume over 120 weeks compared to placebo.
Bone marrow transplantation for thalassemia in lower resource settings - The Cure2Children Foundation experience in Pakistan. By Dr Naila Yaqub, Assistant Professor, Bone Marrow Transplant unit, The Children hospital, PIMS, Pakistan
The document discusses challenges in treating hemophilia in China. It notes complications like inhibitor development and viral infections. Affordability, availability, and patient compliance are also challenges. Adherence to secondary prophylaxis decreases with age. Barriers to prophylaxis include access issues and perceptions of risk. The status of hemophilia care and treatment in China has improved in recent decades due to efforts like establishing a national hemophilia registry and regional networks, expanding insurance coverage and product availability, and increasing awareness and education.
Patient perspective on TKI treatment and monitoring in CMLspa718
This document summarizes the results of a study examining chronic myeloid leukemia (CML) treatment and monitoring patterns from the perspective of patients in China. The study found that over 70% of respondents began tyrosine kinase inhibitor (TKI) treatment within one year of diagnosis, with imatinib being the most commonly used TKI. Most respondents achieved an optimal response but over 60% cited high financial burden as the main obstacle to treatment. While many received regular monitoring, over 30% did not undergo regular molecular testing. The study concludes that expanding insurance coverage, lowering drug costs, and promoting standard monitoring could help improve outcomes for CML patients in China.
HWANG Chung Cheng Jordan, RN, MN, Adv. Dip. (Oncology),
Advanced Practice Nurse – Haematology
Division of Nursing
Department of Haematology
Singapore General Hospital, Singapore
30th October 2016
Thalassemia in Viet Nam by Prof.Nguyen Anh Tri MD Ph.D Director - National institute of Hematology and Blood Transfusion President – Viet Nam Thalassemia Association
The document provides biographical and professional details of Dr. Sujoy Dasgupta, an expert in reproductive medicine. It lists his qualifications and experience in treating male factor infertility and reproductive endocrinology. The document also discusses various evaluations and management strategies for male infertility conditions.
PROJECT CAH NEWBORN SCREENING DBS SPECIMEN COLLECTION AND HANDLING dr saras ...RahimiRamli9
The document describes a pilot study to implement newborn screening for Congenital Adrenal Hyperplasia (CAH) in Malaysia. CAH is caused by mutations that impair steroidogenic enzyme activity and can lead to life-threatening issues if not detected early. The study aims to evaluate methods for CAH newborn screening using dried blood spots to measure 17-hydroxyprogesterone levels, establish local population cut-offs, and allow early detection to prevent health issues from an undiagnosed CAH condition.
Dr. Sujoy Dasgupta is a consultant in reproductive medicine who has extensive qualifications and experience in the field. He lists his academic achievements and positions held at several hospitals in Kolkata. The document provides an overview of Dr. Dasgupta's expertise in evaluating and treating male infertility through a discussion of topics like semen analysis, varicocele, cryptorchidism, hormonal abnormalities, genetic defects, ejaculatory issues, and treatment strategies including IUI, IVF and ICSI.
Role of diffusion weighted magnetic resonance imaging inshubhamoygantait
This document outlines a study examining the role of diffusion weighted magnetic resonance imaging (DWI) in evaluating prostate cancer. The study aims to evaluate suspected prostate cancer cases with DWI and correlate findings with histology. It also aims to compare DWI findings to T2-weighted imaging (T2WI) findings and their combination to see if the multiparametric approach increases cancer detection sensitivity and specificity. The study involves imaging and histological analysis of 100 patients with suspected prostate cancer using 1.5T MRI with endorectal and surface coils. Statistical analysis will correlate imaging findings with histology and stage cancer based on imaging and pathology.
Thalassaemia in Bangladesh by Dr. Waqar Ahmed Khan, MBBS, M.Phil who is Professor of Pathology, Bangladesh Institute of Child Health, Dhaka Shishu (Children) Hospital and President of Dhaka Shishu Hospital Thalassaemia, Dhaka, Bangladesh.
The Bethesda System is a standardized terminology used for reporting cervical and vaginal cytology test results, such as Pap smears. It was established in 1988 at a conference in Bethesda, Maryland and has since been updated in 1991, 2001, and 2014. The system provides a structured format for specimen details, adequacy, interpretation, and any necessary follow-up testing. It aims to improve consistency and reduce ambiguity in cervical cancer screening.
The document discusses newborn screening in India, arguing that it is needed to prevent health issues. It outlines the components of newborn screening programs and principles from Wilson and Jungner. Internationally, most Western countries screen for various treatable genetic disorders. In India, pilot studies found higher rates of congenital hypothyroidism than the West. The document recommends starting screening for congenital hypothyroidism, congenital adrenal hyperplasia, and G6PD deficiency in urban Indian hospitals. It stresses the need for diagnostic confirmation, treatment facilities, and quality assurance before a national newborn screening program is implemented.
Dr Ayman Ewies - Postcoital Bleeding National SurveyAymanEwies
This document discusses the inconsistent management of postcoital bleeding (PCB) by UK doctors and the need for evidence-based guidelines. A survey of UK gynecologists found wide variations in how they manage and investigate PCB. Despite links between PCB and cervical pathology, less than half repeat smear tests for women with a negative history and only 15% refer women directly to colposcopy clinics. The lack of consensus and guidelines on PCB management makes it important to standardize care based on the best evidence.
Dr Ayman Ewies - Managing Women with Postcoital BleedingAymanEwies
This study prospectively observed 120 women referred to a hospital with postcoital bleeding over one year. The study found that over 50% of women were under 35, over 90% had PCB for more than 4 weeks, and 19.2% had severe episodes. Significant pathology was found in 53.8% of women under 35, suggesting age alone may not determine pathology. None of the 11 women with cervical cancer or CIN3 had previous abnormal smears. The study recommends urgent referral for all women with PCB and evaluating all for infections, given the high rate of detected pathology.
This document summarizes a study assessing pre-operative outcomes and their correlation with intra-operative findings for laparoscopic cholecystectomies. It introduces cholelithiasis and laparoscopic cholecystectomy as the gold standard treatment. The study aims to evaluate factors that make laparoscopic cholecystectomy difficult. It employs a pre-operative scoring system based on patient history, exam, and ultrasound findings, and compares it to intra-operative scoring of difficulty. The results show a 91.5% correlation between pre-operative and intra-operative scores. Most pre-operative risk factors were significantly correlated with difficulty. The scoring system was found to reliably predict difficulty of laparoscopic cholecyst
Omair Sana Foundation (OSF) is an initiative taken back in 2002 by a Pakistan-born American doctor, Kashif Hussain Ansari. The Foundation is named after two kids, Omair and Sana, he lost to Blood Diseases. Under his leadership, OSF is run and managed by a group of highly qualified professionals from different walks of life.
- The document discusses the benefits of first trimester antenatal care, including screening for fetal anomalies and maternal-fetal complications. It notes that detailed ultrasound examination and markers in the first trimester can predict many complications later in pregnancy and allow for early intervention. Conditions like Down's syndrome, open neural tube defects, congenital heart defects, preeclampsia, and fetal growth restriction can potentially be detected through a combination of ultrasound assessment, medical history, and serum markers in the first trimester. This represents a shift away from traditional late pregnancy surveillance to an earlier risk assessment approach through innovations in first trimester screening.
Similar to Southern China - Current Situation in Control Strategies and Health Systems in Asia (20)
MRI-based Monitoring Tools for Iron Chelation by Pairash Saiviroonporn, Ph.D., Radiology Department, Faculty of Medicine Siriraj Hospital, Mahidol University
Understanding the molecular mechanisms leading to reactivation or derepression of γ-globin gene by Jim Vadolas, Cell and Gene Therapy Group, Murdoch Childrens Research Institute, Royal Children’s Hospital
Gene therapy aims to cure β-thalassemias by using lentiviral vectors to insert functional β-globin genes into hematopoietic stem cells. The first patient treated achieved long-term transfusion independence with stable multi-year expression of the corrected globin. Analysis found most genetically modified cells contained the vector integrated near the HMGA2 gene, though the majority of cells remained unmodified. Ongoing work continues to optimize the therapy.
This document discusses the multi-disciplinary care needs for patients with thalassaemia. Thalassaemia affects multiple organ systems over time as it progresses from a chronic anemia disease to one that impacts the heart, liver, endocrine system and more. It requires monitoring and treatment from specialists in cardiology, hepatology, endocrinology and others. The optimal approach is for patients to receive care at dedicated thalassaemia centers with a multi-disciplinary team that can coordinate treatment across specialties and properly manage the many complications that can arise for patients with this condition.
Treatment of patients with β-Thalassaemias focuses on improving outcomes through regular blood transfusions and iron chelation therapy to remove excess iron from previous transfusions. Advances in transfusion and chelation regimens have led to significantly improved survival rates over time. Maintaining low levels of iron overload through adherence to chelation therapy and monitoring of iron levels correlates strongly with reduced complications and improved long-term survival and outcomes for patients with thalassaemia major.
Genetic Screening and Prenatal Diagnosis of Thalassemias and Hemoglobinopathies in Taiwan Today by Ching-Tien Peng, MD, MPH, Superintendent & Prof. of The Children’s Hospital, China Medical University & Hospitals, Prof. of Biotechnology, Asia University, Taichung, Taiwan
Taiwan has a population of over 23 million people with a GDP per capita of $18,603. The country implemented a National Health Insurance program in 1995 that provides coverage for inpatient, outpatient, and limited home care. Thalassemia is prevalent in Taiwan, with carrier rates of 5-8% for various types. The country has a national prevention program that screens pregnant women and provides confirmatory testing and genetic counseling. Treatment for thalassemia major includes regular blood transfusions paid for by National Health Insurance as well as iron chelation therapy. Multidisciplinary expert centers provide coordinated care and management for patients.
Thalassaemia is present among Australia's ethnically diverse population. There is no national registry or standardized antenatal screening policy. Estimates indicate around 326 patients with beta thalassaemia major nationally, though numbers may be higher without a registry. Diagnostic testing and genetic counseling are available through specialist centers and hospital laboratories nationwide.
CURRENT SITUATION IN CONTROL STRATEGIES & HEALTH SYSTEMS IN ASIA - CAMBODIA by PRAK PISETH RAINGSEY, MD, DND, MPH Director Preventive Medicine Department MINISTRY OF HEALTH
Current Situation in Control Strategies and Health Systems in Philippines by ERNESTO d’J. YUSON MD, Thalassemia Center of the Philippines, Balikatang Thalassaemia
Thalassemia in Laos: Situation Analysis by Dr. Sourideth Sengchanh, Dr. Alongkone Phengsavanh, Assoc. Prof. Dr. Khampe Phongsavat, University of Health Sciences, Vientiane, Laos. Presented by Assoc. Prof. Dr. Khampe Phongsavat.
Current Situation in Control Strategies and Health Systems in Myanmar, Asia by PROFESSOR DR. NE WIN, DIRECTOR (LABORATORY AND BLOOD SERVICE), MINISTRY OF HEALTH, UNION OF MYANMAR
More from Thalassaemia International Federation (20)
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...Jim Jacob Roy
In this presentation , SBP ( spontaneous bacterial peritonitis ) , which is a common complication in patients with cirrhosis and ascites is described in detail.
The reference for this presentation is Sleisenger and Fordtran's Gastrointestinal and Liver Disease Textbook ( 11th edition ).
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Nutritional deficiency Disorder are problems in india.
It is very important to learn about Indian child's nutritional parameters as well the Disease related to alteration in their Nutrition.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The Children are very vulnerable to get affected with respiratory disease.
In our country, the respiratory Disease conditions are consider as major cause for mortality and Morbidity in Child.
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Southern China - Current Situation in Control Strategies and Health Systems in Asia
1. 1st Pan-Asia Conference on Haemoglobinopathies
Prevention and control of
thalassaemia in Southern China
Guangxi Province
Ping Chen
Guangxi Medical University
g y
3. Guangxi Zhuang Autonomous Region &
G i Zh A t R i
Guangdong province
Guangxi Province Guangdong Province
Population 50 million 80 million
Area 240,100 179,800
Ethnic group 37 53
Han: 61.46% 98.6%
Minority groups: 38.54% 1.4%
Annual births 720, 000 1 million
4. The Ca e rate for t a asse a
e Carrier ate o thalassemia
Carrier rate for Carrier rate for Carrier rate for
province -thalassemia(%) -thalassemia(%) Hb E(%)
Guangxi 14.95 5.65 0.009
Guangdong 8.53 2.54 NA
16
14
12
10
Guangxi
8 Guangdong
G d
Hongkong
6
Taiwan
4
2
0
alpha-thalassemia beta-halassemia
5. Estimated number of patients
st ated u be o pat e ts
province Annual births Hydrop foetalis -thalassemia major
Guangxi 720,000/yr
720 000/yr 4050/yr 574/yr
Guangdong 1,000,000/yr 7276/yr 645/yr
6. Prevention and control program of
p g
Thalassemia in Southern China (Since 1983)
• 1960s: thalassemia research began.
• 1983 -thalassemia genotyping and prenatal diagnosis were
1983: th l i t i d t l di i
established and have been performed.
• 1987: Prenatal diagnosis for -thalassemia started.
• 1998: iron chelation and stem cell transplantation for patients
p p
with -thalassemia major.
• 2004: separate fetal DNA in maternal plasma for - and
-thalassemia prenatal diagnosis.
• 2007: Preimplantation genetic diagnosis for thalassemia.
thalassemia
7. Support f
S t from th Ministry of Health of China &
the Mi i t f H lth f Chi
Government of Guangxi Province
The Ministry of Health of China and Guangxi government signed
agreement for prevention and control of thalassemia
tf ti d t l f th l i
March 11, 2010
8. Prevention and control program for thalassemia
in Guangxi province (2010)
• Enhancing health education
• Setting up more centers for screening and diagnosis of
thalassemia
• Training medical doctors, nurses, technicians and health
workers
• Provision of free screening to premarital couples
• Free prenatal diagnosis
9. Prevention and control program for thalassemia
in Guangdong province (2010)
• “Maternal and Children s Safety and Health Project
Maternal Children’s Project”
including screening and prenatal diagnosis to reduce the
birth rate of thalassemia major.
j
• Only a few cities provide free screening for thalassemia
carriers.
10. Techniques available
• Blood count:
in all clinics and hospitals.
• Electrophoresis:
hospitals in counties and cities.
• Automatic HPLC systems or Capillarys:
y p y
hospitals in counties and cities.
• DNA analysis:
some hospitals in cities.
13. Population Screen for Thalassemia
• Screening for carriers
Clinics / Hospital outpatients
Population
• Walk in for voluntary screening
• Specific target groups
14. Specific target groups:
• Premarital couples
• pregnant women and husbands
p g
• Adolescents and young adults
• neonates
15. Prenatal diagnosis in Guangxi Province
(since 1983)
• Obtain fetal DNA:
Chorionic villus sampling
Amninocentesis
Foetal blood sampling
• DNA analysis:
Gap PCR, RDB, DNA sequencing.
16. Prenatal diagnosis centers in Guangxi Province
1 in Liuzhou 2 in Guilin
1 in Baise
1 in Baise
1 in
3 in Nanning
Wuzhou
1 in
Yulin
18. Treatment for patients
• Iron Chelation:
Desferrioxamine
Deferiprone
Exjade
• Steam cell transplantation
• Medical insurance cover blood transfusion and iron
chelation, and some expense for transplantation.
20. Regular professional education and training
R l f i l d ti dt i i
• Obstetricians, pediatricians, hematologists, nurses
and technicians must receive education and training,
and obtain the qualification for the management of
thalassemia.
thalassemia
• Course workshops seminars and conferences.
Course, workshops, conferences
• organized by the Department of Health of Guangxi
government, Guangxi Medical University etc.
21. The 3rd International Conference on Thalassemia in China & The
2nd Asia Pacific Iron A d
2 d A i P ifi I Academy C f
Conference, 2010
Organizer:
1.
1 Guangxi Medical
University
2. Institute of Molecular
Biosciences, Mahidol
University
3.
3 Asia Pacific Iron
Academy
22.
23. Overall Meeting Evaluation
O ll M ti E l ti
50
45
40
35
30
25
20 # of participants
15
10
5
0
• Total individuals: 253
• China 55 vs. overseas 198
29. Team: 26 staffs
O t ti t department
Out-patient d t t
W d
Ward
L b
Laboratory
t
30. Management for thalassemia
Clinical
Cli i l work:
k
• Genetic counseling
• Hb Analysis
• DNA analysis
• Prenatal diagnosis:
• Patients treatmnet
Training:
• seminars
• workshops
g
• 3 months training
31. The Th l
Th Thalassemia Research Center
i R hC t
• The National Key Clinical Specialty for Thalassemia,
approved by the Ministry of Health of China.
• The Key laboratory in Thalassemia Research
• Guangxi Prenatal diagnosis Center for Thalassmia
• The Training Center for medical professionals